VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HYFT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HYFTMindWalk Holdings Corp.
$1.58$74M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

HYFT logoMindWalk Holdings Corp.(HYFT)Earnings, Financials & Key Ratios

HYFT•NASDAQ
$1.58
Price updated Jun 27, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryDrug Discovery and Antibody Platforms
AboutMindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.Show more
  • Revenue$25M
  • EBITDA-$7M+11.8%
  • Net Income-$30M-15.8%
  • EPS (Diluted)-0.90+12.6%
  • Gross Margin55.25%+12.4%
  • EBITDA Margin-28.86%+11.8%
  • Operating Margin-49.74%+11.4%
  • Net Margin-123.3%-15.8%
  • ROE-105.08%-84.5%

HYFT Price & Volume

MindWalk Holdings Corp. (HYFT) stock price & volume — 10-year historical chart

Loading chart...

Persistent Operational Losses Threaten Strategic AI Pivot

Investment Thesis • Updated 2026Q3

VerdictNegative: The company's precarious liquidity position
Growth:Mixed
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Capital exhaustion and dilution

Key Thesis Takeaways

  • MindWalk Holdings faces a precarious transition from a legacy CRO model to an AI-driven discovery platform, characterized by significant value destruction and a shrinking asset base.
  • The company's inability to achieve operating leverage, evidenced by SG&A expenses consistently exceeding $4M per quarter, suggests that current revenue streams are insufficient to support its R&D ambitions.
  • Investors should remain cautious as the firm's reliance on external financing to bridge its cash burn, coupled with an accumulated deficit of $139.9M, indicates a high probability of further dilutive equity issuance.

Verdict Logic

underscored by a cash balance of only $14.2M against recurring quarterly net losses, suggests a high risk of capital exhaustion and shareholder dilution.

HYFT Growth Metrics

MindWalk Holdings Corp. (HYFT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years10.74%
3 Years8.19%
TTM3.35%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM73.59%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM81.9%

Return on Capital

10 Years-21.59%
5 Years-23.28%
3 Years-27.66%
Last Year-27.94%

Peers Comparison

Key metrics vs top competitors for MindWalk Holdings Corp. (HYFT)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
HYFT logoHYFTMindWalk Holdings Corp.Current
$1.58$73.8M-2.490.01%-123.3%-105.08%—
MNMD logoMNMDMind Medicine (MindMed) Inc.
$20.69$2.04B-10.04——-102.48%—
CMPS logoCMPSCOMPASS Pathways plc
$14.82$1.42B-4.81——-151.02%—
ATAI logoATAIAtai Beckley N.V
$5.29$1.95B-1.821227.6%-19019.44%-366.21%—
CYBN logoCYBNCybin Inc.
$6.09$303.86M-13.66——-81%—
SILO logoSILOSilo Pharma, Inc.
$6.05$5.47M-0.81—-6717.4%-88.41%—

Compare HYFT vs Peers

MindWalk Holdings Corp. (HYFT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs MNMD

Most directly comparable listed peer for HYFT.

Scale Benchmark

vs HIMS

Larger-name benchmark to compare HYFT against a more recognizable public peer.

Peer Set

Compare Top 5

vs MNMD, CMPS, ATAI, CYBN

Get notified when HYFT posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

HYFT Frequently Asked Questions

MindWalk Holdings Corp. (HYFT) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is MindWalk Holdings Corp.'s revenue?

MindWalk Holdings Corp. (HYFT) reported $18.4M in revenue for fiscal year 2025. This represents a 281222% increase from $0.0M in 1997.

How fast is MindWalk Holdings Corp. growing?

MindWalk Holdings Corp. (HYFT) grew revenue by 0.0% over the past year. Growth has been modest.

Is HYFT profitable?

MindWalk Holdings Corp. (HYFT) reported a net loss of $12.2M for fiscal year 2025.

Dividend & Returns
What is HYFT's return on equity?

MindWalk Holdings Corp. (HYFT) has a return on equity (ROE) of -105.1%. Negative ROE indicates the company is unprofitable.

What is MindWalk Holdings Corp.'s free cash flow?

MindWalk Holdings Corp. (HYFT) had negative free cash flow of $11.9M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in HYFT back in 1997?

Total return calculator · dividends reinvested · 29+ years of data

See returns →